USPTO serial 97132863
EGENE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 1, 2023
- Examiner
- HARDY LUDLOW, TARAH KIM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz VENABLE LLPP.O. BOX 34385WASHINGTON, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides and synthetic proteins for scientific and industrial use; all for expression of proteins and none being mutation detection reagents, genome editing reagents, or polynucleotide assembly reagents | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides, synthetic proteins for clinical or medical use; DNA and RNA products for medical use, namely, nucleic acid sequences, genes and proteins; therapeutic DNA and RNA products, namely, nucleic acid sequences, genes and proteins for medical and veterinary purposes; vaccines; all for expression of proteins and none being mutation detection reagents, genome editing reagents, or polynucleotide assembly reagents | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, scientific desktop instruments for DNA, RNA, gene and protein synthesis; scientific desktop instruments for DNA, RNA, gene and protein synthesis, namely, microfluidic devices; medical laboratory research instrument in the nature of desktop instrument cartridges for DNA, RNA, gene and protein synthesis, namely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors for scientific, research or industrial purposes in DNA, RNA, gene and protein synthesis; bio-chips for scientific, research or industrial purposes; scientific research and laboratory apparatus, namely, apparatus and instruments for amplifying DNA and RNA, reactors, bioreactors, and laboratory apparatus and instruments for amplifying DNA and RNA using polymerase chain reaction (PCR); apparatus and instruments for synthesising DNA and RNA, namely, microarrays, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips; scientific research and laboratory apparatus, namely, apparatus and instruments for processing DNA and RNA, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips; computer hardware, recorded computer software, downloadable computer software, and downloadable bioinformatics software for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology and medical science | ACTIVE | — |
| 010 | Apparatus and instruments for DNA, RNA, gene and protein synthesis for medical and veterinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NUCLERA LTD
- Other trademarks owned by NUCLERA LTD
- Other trademarks owned by Nuclera Nucleics Limited
- Other trademarks owned by Nuclera Nucleics Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named EGENE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 1, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 14, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 16, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 16, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 26, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 13, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 13, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 11, 2023 | ALIE | ASSIGNED TO LIE | — |
| Mar 30, 2023 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 30, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 31, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 22, 2021 | NWAP | NEW APPLICATION ENTERED | — |